| Stage | RXO | % of rev | BKNG | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $1.9B | 100.00% | $7.4B | 100.00% | BKNG ×3.93 |
| Gross profit | $333M | 17.80% | $7.4B | 100.00% | BKNG +82.2pp |
| Operating income | $17M | 0.91% | $2.5B | 34.00% | BKNG +33.1pp |
| Pre-tax income | $6M | 0.32% | $2.6B | 34.82% | BKNG +34.5pp |
| Net income | $3M | 0.16% | $1.9B | 26.52% | BKNG +26.4pp |
| Stage | RXO | BKNG | Gap · A − B |
|---|---|---|---|
| Revenue | $1.9B100.00% | $7.4B100.00% | BKNG ×3.93 |
| Gross profit | 17.80%$333M | 100.00%$7.4B | BKNG +82.2pp |
| Operating income | 0.91%$17M | 34.00%$2.5B | BKNG +33.1pp |
| Pre-tax income | 0.32%$6M | 34.82%$2.6B | BKNG +34.5pp |
| Net income |
| 0.16%$3M |
| 26.52%$1.9B |
| BKNG +26.4pp |